Abstract:Mingjie Shi, 1, 2 Yue Wei, 3 Runmin Guo, 1, 2 Fei Luo 1, 2 1 Key Laboratory of Research in Maternal and Child Medicine and Birth Defects, Guangdong Medical University, Foshan, Guangdong, People's Republic of China; 2 Matenal and Child Research Institute, Shunde Women and Children's Hospital (Maternity and Child Healthcare Hospital of Shunde Foshan), Guangdong Medical University, Foshan, People's Republic of China; 3 Department of Ultrasound, Shunde Women and Children's Hospital (Maternity and Child Healthcare Hospital of Shunde Foshan), Guangdong Medical University, Foshan, People's Republic of China Correspondence: Fei Luo, Shunde Women and Children's Hospital (Maternity and Child Healthcare Hospital of Shunde Foshan), Guangdong Medical University, Foshan, People's Republic of China, Email Background: Sepsis is a major contributor to morbidity and mortality among hospitalized patients. This study aims to identify markers associated with the severity and prognosis of sepsis, providing new approaches for its management and treatment. Methods: Data were mined from the Gene Expression Omnibus (GEO) databases and were analyzed by multiple statistical methods like the Spearman correlation coefficient, Kaplan-Meier analysis, Cox regression analysis, and functional enrichment analysis. Candidate indicator' associations with immune infiltration and roles in sepsis development were evaluated. Additionally, we employed techniques such as flow cytometry and neutral red staining to evaluate its impact on macrophage functions like polarization and phagocytosis. Results: Twenty-eight genes were identified as being closely linked to the severity of sepsis, among which transforming growth factor beta induced (TGFBI) emerged as a distinct marker for predicting clinical outcomes. Notably, reductions in TGFBI expression during sepsis correlate with poor prognosis and rapid disease progression. Elevated expression of TGFBI has been observed to mitigate abnormalities in sepsis-related immune cell infiltration that are critical to the pathogenesis and prognosis of the disease, including but not limited to type 17 T helper cells and activated CD8 T cells. Moreover, the protein-protein interaction network revealed the top ten genes that interact with TGFBI, showing significant involvement in the regulation of the actin cytoskeleton, extracellular matrix-receptor interactions, and phagosomes. These are pivotal elements in the formation of phagocytic cups by macrophages, squaring the findings of the Human Protein Atlas. Additionally, we discovered that TGFBI expression was significantly higher in M2-like macrophages, and its upregulation was found to inhibit lipopolysaccharide-induced polarization and phagocytosis in M1-like macrophages, thereby playing a role in preventing the onset of inflammation. Conclusion: TGFBI warrants additional exploration as a promising biomarker for assessing illness severity and prognosis in patients with sepsis, considering its significant association with immunological and inflammatory responses in this condition. Keywords: sepsis, septic shock, TGFBI, prognosis, biomarker Sepsis is a life-threatening condition characterized by an abnormal response of the body to an infection caused by bacteria, viruses, or other pathogens. 1 It begins with an inflammatory reaction and immune system activation. Symptoms such as a high temperature, racing heart, and difficulty breathing may manifest at this stage, while vital signs like blood pressure and organ function are often unaffected. The inflammation can worsen and spread throughout the body if the infection is not adequately controlled, eventually leading to severe sepsis, which is characterized by symptoms of organ dysfunction such as decreased urine output, altered state of consciousness, and hypotension, posing a serious threat to the patient's life. 2,3 Septic shock is the most serious stage, characterized by persistent hypotension and poor response to fluid resuscitation, which often leads to multi-organ failure of the heart, lungs, kidneys, liver and other organs, and is prone to serious complications such as refractory hypotension, metabolic acidosis, and coagulation disorders, and is the main cause of disability and death in hospitalized patients. 2,4 Hence, the management of sepsis centres around promptly identifying and intervening to halt its advancement towards severe sepsis or shock, thereby diminishing the likelihood of grave sequelae and mortality. Recent years have seen an uptick in the amount of studies focusing on sepsis biomarkers, which have revealed markers not only for predicting the overall diagnosis and prognosis of sepsis -Abstract Truncated-

The Predictive Value of Heparin-Binding Protein and D-Dimer in Patients with Sepsis

Multi-biomarker Strategy for Prediction of Myocardial Dysfunction and Mortality in Sepsis

Heparin-binding Protein As a Biomarker of Severe Sepsis in the Pediatric Intensive Care Unit: A Multicenter, Prospective Study

Heparin-binding protein as a predictive and diagnostic biomarker for severe sepsis and septic shock in patients with sepsis

Dynamic changes in heparin-binding protein as a prognostic biomarker for 30-day mortality in sepsis patients in the intensive care unit

Comparison of the clinical value of plasma heparin-binding protein, procalcitonin and C-reactive protein in the early diagnosis of sepsis

Usefulness of the heparin-binding protein level to diagnose sepsis and septic shock according to Sepsis-3 compared with procalcitonin and C reactive protein: a prospective cohort study in China

Diagnostic Value of Serum Heparin Binding Protein, Blood Lactic Acid Combined with hs-CRP in Sepsis and Its Relationship with Prognosis

Heparin-binding protein as a biomarker for the diagnosis of sepsis in the intensive care unit: a retrospective cross-sectional study in China

The performance of a combination of heparin-binding protein with other biomarkers for sepsis diagnosis: an observational cohort study

A Promising Candidate: Heparin-Binding Protein Steps onto the Stage of Sepsis Prediction

Accuracy of Heparin-Binding Protein in Diagnosing Sepsis: A Systematic Review and Meta-Analysis

Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock

Diagnostic and prognostic value of heparin-binding protein in sepsis: A systematic review and meta-analysis

Inverse Correlation Between Plasma Sphingosine-1-Phosphate and Ceramide Concentrations in Septic Patients and Their Utility in Predicting Mortality.

Heparin-binding protein-enhanced quick SOFA score improves mortality prediction in sepsis patients

Sepsis biomarkers in unselected patients on admission to intensive or high-dependency care

Changes in Heparin-Binding Protein, Procalcitonin, and C-Reactive Protein Within the First 72 Hours Predict 28-Day Mortality in Patients Admitted to the Intensive Care Unit with Septic Shock

Hepcidin discriminates sepsis from other critical illness at admission to intensive care

Heparin‐binding protein: a key player in the pathophysiology of organ dysfunction in sepsis

Integrated Analysis Identified TGFBI as a Biomarker of Disease Severity and Prognosis Correlated with Immune Infiltrates in Patients with Sepsis